XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities    
Net income $ 552 $ 1,768
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation expense 2,640 1,337
Amortization of intangible assets 7,133 4,049
Tax expense from stock issuances 315 110
Amortization of deferred financing costs 739 130
Loss on sublease 578  
Stock-based compensation 5,383 5,180
Change in fair value of contingent consideration 145 (279)
Changes in accounts receivable allowance 398 (16)
Deferred tax benefit (2,338) (1,267)
Loss on disposal of fixed assets 23  
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (10,424) 2,341
Prepaid expense and other assets 1,628 (1,516)
Accounts payable (1,458) 38
Deferred revenue (980) (1,408)
Debt issuance costs (38) 198
Accrued expenses (1,023) 829
Net cash provided by operating activities 3,273 11,494
Cash flows from investing activities    
Acquisitions, net of cash acquired (889) (1,862)
Restricted cash 405 56
Purchase of furniture, fixtures and equipment (2,270) (1,904)
Net cash used in investing activities (2,754) (3,710)
Cash flows from financing activities    
Proceeds from debt   13,500
Principal payments on borrowings (7,151) (4,850)
Proceeds from issuance of ESPP shares 494 444
Payment of contingent consideration (2,665) (2,483)
Payment for acquisition of Experton (543)  
Payments related to tax withholding for stock-based compensation (2,174) (1,576)
Debt issuance costs   9
Tax expense from stock issuances   (110)
Equity securities repurchased (2,853) (11,441)
Net cash used in financing activities (14,892) (6,507)
Effect of exchange rate changes on cash 2,115 21
Net (decrease) increase in cash and cash equivalents (12,258) 1,298
Cash and cash equivalents, beginning of period 34,485 17,835
Cash and cash equivalents, end of period 22,227 19,133
Noncash financing activities:    
Issuance of treasury stock for vested restricted stock awards $ 6,437 $ 4,973